Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Astri Therapeutics Inc (NQ: ATXS ) 11.05 -0.28 (-2.47%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 439,445 Open 11.25 Bid (Size) 9.180 (3) Ask (Size) 13.03 (1) Prev. Close 11.33 Today's Range 10.88 - 11.51 52wk Range 4.260 - 16.90 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 02, 2024 From Astria Therapeutics Via Business Wire Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 04, 2024 From Astria Therapeutics, Inc. Via Business Wire Performance YTD +41.85% +41.85% 1 Month +22.91% +22.91% 3 Month +4.84% +4.84% 6 Month +55.41% +55.41% 1 Year +17.43% +17.43% More News Read More Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference May 30, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present at Upcoming Eastern Allergy Conference May 24, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress May 23, 2024 From Astria Therapeutics, Inc. Via Business Wire ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q1 2024 May 09, 2024 Via InvestorPlace Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update May 09, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting May 08, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 02, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics Appoints Sunil Agarwal to Its Board of Directors April 09, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 03, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE March 25, 2024 From Astria Therapeutics, Inc. Via Business Wire Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 20, 2024 Via Benzinga Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 05, 2024 From Astria Therapeutics, Inc. Via Business Wire ATXS Stock Earnings: Astria Therapeutics Misses EPS for Q4 2023 March 04, 2024 Via InvestorPlace Astria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update March 04, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meeting February 20, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conference February 06, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) February 05, 2024 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics Announces Pricing of $125 Million Underwritten Offering January 30, 2024 From Astria Therapeutics, Inc. Via Business Wire 12 Health Care Stocks Moving In Thursday's Pre-Market Session January 25, 2024 Via Benzinga $5.6M Bet On This Real Estate Stock? Check Out These 3 Stocks Insiders Are Buying December 26, 2023 Via Benzinga Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) December 04, 2023 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present STAR-0215 Data at the 2023 World Allergy Congress November 27, 2023 From Astria Therapeutics, Inc. Via Business Wire Astria Therapeutics to Present at Upcoming 6th Annual Evercore ISI HealthCONx Conference November 21, 2023 From Astria Therapeutics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.